Weicang Wang

2.0k total citations
44 papers, 1.4k citations indexed

About

Weicang Wang is a scholar working on Biochemistry, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Weicang Wang has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biochemistry, 16 papers in Molecular Biology and 12 papers in Nutrition and Dietetics. Recurrent topics in Weicang Wang's work include Eicosanoids and Hypertension Pharmacology (18 papers), Fatty Acid Research and Health (10 papers) and Cancer, Lipids, and Metabolism (6 papers). Weicang Wang is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (18 papers), Fatty Acid Research and Health (10 papers) and Cancer, Lipids, and Metabolism (6 papers). Weicang Wang collaborates with scholars based in United States, China and Japan. Weicang Wang's co-authors include Guodong Zhang, Bruce D. Hammock, Haixia Yang, Katherine Z. Sanidad, Hang Xiao, Dipak Panigrahy, Julia Zhu, Zheyuan Du, Elvira Sukamtoh and Yuxin Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Weicang Wang

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weicang Wang United States 23 569 249 209 146 144 44 1.4k
Jiro Ogura Japan 22 748 1.3× 150 0.6× 183 0.9× 144 1.0× 77 0.5× 73 2.1k
Katherine Z. Sanidad United States 20 454 0.8× 93 0.4× 135 0.6× 71 0.5× 231 1.6× 33 1.1k
Haixia Yang China 31 1.1k 2.0× 163 0.7× 302 1.4× 169 1.2× 80 0.6× 110 2.4k
Jun Han China 25 611 1.1× 97 0.4× 144 0.7× 78 0.5× 59 0.4× 96 1.5k
Kalyan C. Nagulapalli Venkata United States 15 436 0.8× 47 0.2× 156 0.7× 117 0.8× 84 0.6× 18 1.5k
Alicja Kuban‐Jankowska Poland 18 649 1.1× 60 0.2× 157 0.8× 142 1.0× 51 0.4× 47 1.8k
Yann‐Lii Leu Taiwan 35 1.0k 1.8× 100 0.4× 94 0.4× 168 1.2× 96 0.7× 90 2.8k
Claude Saliou United States 12 600 1.1× 93 0.4× 208 1.0× 206 1.4× 26 0.2× 17 1.6k
Wojciech Łuczaj Poland 20 495 0.9× 89 0.4× 162 0.8× 71 0.5× 28 0.2× 55 1.7k

Countries citing papers authored by Weicang Wang

Since Specialization
Citations

This map shows the geographic impact of Weicang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weicang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weicang Wang more than expected).

Fields of papers citing papers by Weicang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weicang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weicang Wang. The network helps show where Weicang Wang may publish in the future.

Co-authorship network of co-authors of Weicang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Weicang Wang. A scholar is included among the top collaborators of Weicang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weicang Wang. Weicang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Weicang, Christophe Morisseau, Xiaoyue Xiao, et al.. (2025). Microbial biotherapeutic metabolite alleviates liver injury by restoring hepatic lipid metabolism through PPARα across the gut-liver axis. mBio. 16(9). e0171825–e0171825. 2 indexed citations
2.
Wang, Weicang, Jun Yang, Molly M. Gilligan, et al.. (2024). Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase. Proceedings of the National Academy of Sciences. 121(7). e2314085121–e2314085121. 12 indexed citations
3.
Wang, Weicang, Yuxin Wang, Karen Wagner, et al.. (2023). Aflatoxin B1 Increases Soluble Epoxide Hydrolase in the Brain and Induces Neuroinflammation and Dopaminergic Neurotoxicity. International Journal of Molecular Sciences. 24(12). 9938–9938. 10 indexed citations
4.
Wang, Weicang, Karen Wagner, Yuxin Wang, et al.. (2023). Soluble Epoxide Hydrolase Contributes to Cell Senescence and ER Stress in Aging Mice Colon. International Journal of Molecular Sciences. 24(5). 4570–4570. 8 indexed citations
5.
Wang, Weicang, Yuxin Wang, Jun Yang, et al.. (2022). Aflatoxin B1 exposure disrupts the intestinal immune function via a soluble epoxide hydrolase-mediated manner. Ecotoxicology and Environmental Safety. 249. 114417–114417. 12 indexed citations
6.
Zhou, Jingyi, Weicang Wang, Jianan Zhang, et al.. (2020). Click chemistry-based imaging to study the tissue distribution of the curcumin–protein complex in mice. Food & Function. 11(2). 1684–1691. 1 indexed citations
7.
Fishbein, Anna, Weicang Wang, Haixia Yang, et al.. (2020). Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression. Proceedings of the National Academy of Sciences. 117(35). 21576–21587. 54 indexed citations
8.
Wang, Weicang, et al.. (2020). ω-3 Polyunsaturated Fatty Acids on Colonic Inflammation and Colon Cancer: Roles of Lipid-Metabolizing Enzymes Involved. Nutrients. 12(11). 3301–3301. 24 indexed citations
9.
Hammock, Bruce D., Weicang Wang, Molly M. Gilligan, & Dipak Panigrahy. (2020). Eicosanoids. American Journal Of Pathology. 190(9). 1782–1788. 103 indexed citations
10.
Yang, Haixia, Katherine Z. Sanidad, Weicang Wang, et al.. (2019). Triclocarban exposure exaggerates colitis and colon tumorigenesis: roles of gut microbiota involved. Gut Microbes. 12(1). 1690364–1690364. 38 indexed citations
11.
Hao, Tingting, Zhoujie Xie, Min Wang, et al.. (2019). An anaerobic bacterium host system for heterologous expression of natural product biosynthetic gene clusters. Nature Communications. 10(1). 3665–3665. 41 indexed citations
12.
Wang, Qingwei, Xiao Gao, Tong Yu, et al.. (2018). REGγ Controls Hippo Signaling and Reciprocal NF-κB–YAP Regulation to Promote Colon Cancer. Clinical Cancer Research. 24(8). 2015–2025. 45 indexed citations
13.
Yang, Haixia, Weicang Wang, & Guodong Zhang. (2018). Consumer Antimicrobials on Gut Microbiota and Gut Health. DNA and Cell Biology. 38(1). 7–9. 5 indexed citations
14.
Zhang, Jianan, Jun Yang, Weicang Wang, et al.. (2018). Pharmacological inhibition or genetic ablation of soluble epoxide hydrolase attenuates obesity‐induced nonalcoholic fatty liver disease. The FASEB Journal. 32(S1). 1 indexed citations
15.
16.
Wang, Weicang, et al.. (2017). Chemistry and biology of ω-3 PUFA peroxidation-derived compounds. Prostaglandins & Other Lipid Mediators. 132. 84–91. 37 indexed citations
17.
Wang, Weicang, Jun Yang, Kin Sing Stephen Lee, et al.. (2017). ω-3 Polyunsaturated fatty acids and their cytochrome P450-derived metabolites suppress colorectal tumor development in mice. The Journal of Nutritional Biochemistry. 48. 29–35. 33 indexed citations
18.
Wang, Weicang, et al.. (2015). Allicin inhibits lymphangiogenesis through suppressing activation of vascular endothelial growth factor (VEGF) receptor. The Journal of Nutritional Biochemistry. 29. 83–89. 17 indexed citations
19.
Wang, Weicang, Julia Zhu, Fei Lyu, et al.. (2014). ω-3 Polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer. Prostaglandins & Other Lipid Mediators. 113-115. 13–20. 111 indexed citations
20.
Wang, Ying, Lei Li, Li Zhou, et al.. (2013). Site-specific Acetylation of the Proteasome Activator REGγ Directs Its Heptameric Structure and Functions. Journal of Biological Chemistry. 288(23). 16567–16578. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiro Ogura Breakdown of academic impact, for papers by Katherine Z. Sanidad Breakdown of academic impact, for papers by Haixia Yang Breakdown of academic impact, for papers by Jun Han Breakdown of academic impact, for papers by Kalyan C. Nagulapalli Venkata Breakdown of academic impact, for papers by Alicja Kuban‐Jankowska Breakdown of academic impact, for papers by Yann‐Lii Leu Breakdown of academic impact, for papers by Claude Saliou Breakdown of academic impact, for papers by Wojciech Łuczaj
Rankless by CCL
2026